Tag Archives: GLPG

Best Bank Stocks For 2018

BidaskClub upgraded shares of The Ultimate Software Group (NASDAQ:ULTI) from a hold rating to a buy rating in a report published on Friday.

Several other brokerages also recently weighed in on ULTI. TheStreet upgraded shares of The Ultimate Software Group from a c+ rating to a b- rating in a research report on Tuesday. Wedbush downgraded shares of The Ultimate Software Group from an outperform rating to a neutral rating and boosted their price objective for the stock from $234.00 to $255.00 in a research report on Wednesday, March 14th. Mizuho restated a buy rating and set a $270.00 price objective on shares of The Ultimate Software Group in a research report on Tuesday, April 24th. JMP Securities boosted their price objective on shares of The Ultimate Software Group from $230.00 to $260.00 and gave the stock a market outperform rating in a research report on Tuesday, April 17th. Finally, SunTrust Banks boosted their price objective on shares of The Ultimate Software Group from $250.00 to $280.00 and gave the stock a buy rating in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and eighteen have given a buy rating to the company’s stock. The Ultimate Software Group has an average rating of Buy and an average target price of $253.29.

Best Bank Stocks For 2018: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By Stephen Mack]

    Our investing experts have made some tremendous picks over the last several years, outperforming the S&P 500 by 100%, 200%, or even as much as 700% in the case of Money Morning Executive Editor Bill Patalon’s 2012 pick of Galapagos NV (Nasdaq: GLPG).

  • [By Brian Feroldi, Keith Speights, and Sean Williams]

    Around 44,000 CF patients have gene mutations that are addressable by Vertex’s current drugs. The company is moving forward with several late-stage studies of new triple-drug combinations that hold the potential to treat another 24,000 CF patients.While AbbVie (NYSE:ABBV) and Galapagos (NASDAQ:GLPG) are also developing triple-drug CF combos, Vertex has a clear head start.

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view,Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG)should be at the top of your idea list right now. Read on to find out why.

Best Bank Stocks For 2018: Globus Maritime Limited(GLBS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Media coverage about Globus Maritime (NASDAQ:GLBS) has trended somewhat positive recently, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Globus Maritime earned a news impact score of 0.09 on Accern’s scale. Accern also assigned news articles about the shipping company an impact score of 45.6853785900783 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

Best Bank Stocks For 2018: Check Point Software Technologies Ltd.(CHKP)

Advisors’ Opinion:

  • [By Leo Sun]

    Those numbers look dismal compared to the company’s cybersecurity peers. For example, Symantec’s bigger industry peer Check Point Software (NASDAQ:CHKP)is expected to post 2% sales growth and 5% earnings growth, yet its stock trades at just 17 times this year’s earnings.

  • [By Nicholas Rossolillo]

    For investors looking for a cybersecurity stock, I think a bigger security company like Palo Alto Networks or Check Point Software Technologies (NASDAQ:CHKP) would be a better option. At this juncture, I think FireEye’s high expenditures and sluggish revenue growth outweigh the potential benefits of buying the stock.

  • [By Harsh Chauhan]

    Check Point Software Technologies (NASDAQ:CHKP) plies its trade in the fast-growing cybersecurity market — a market that’s expected to hit $96 billion in revenue this year, an increase of 8% over 2017, accordingto Gartner’s estimates. However, one look at the cybersecurity specialist’s recent performance indicates that it hasn’t been able to capitalize on that vast potential.

  • [By Chris Lange]

    Check Point Software Technologies Ltd.s (NASDAQ: CHKP) short interest decreased to 8.24 million shares from the previous reading of 8.45 million. Shares were trading at $102.91, in a 52-week range of $95.03 to $119.20.

Best Bank Stocks For 2018: Grifols, S.A.(GRFS)

Advisors’ Opinion:

  • [By Shane Hupp]

    Grifols (NASDAQ:GRFS) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Wednesday.

  • [By Max Byerly]

    Financial Gravity Companies Inc. raised its stake in shares of Grifols (NASDAQ:GRFS) by 264.0% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 13,862 shares of the biotechnology company’s stock after purchasing an additional 10,054 shares during the quarter. Financial Gravity Companies Inc.’s holdings in Grifols were worth $282,000 as of its most recent filing with the SEC.

Best Bank Stocks For 2018: B&G Foods, Inc.(BGS)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares rose 35.8 percent to $3.00.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares surged 32 percent to $8.94 after reporting upbeat Q1 earnings.
    Carbon Black, Inc. (NASDAQ: CBLK) gained 29.6 percent to $24.62. Carbon Black priced its IPO at $19 per share.
    California Resources Corporation (NYSE: CRC) shares rose 26.8 percent to $32.70 following upbeat Q1 earnings.
    Pandora Media, Inc. (NYSE: P) gained 25 percent to $7.185 after reporting strong quarterly results.
    Medifast, Inc. (NYSE: MED) shares climbed 23.7 percent to $122.87 after the company reported strong Q1 results and raised its FY18 guidance.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.2 percent to $8.4999 after reporting Q2 results.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) gained 22.2 percent to $41.27 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Shake Shack Inc (NYSE: SHAK) rose 22.2 percent to $57.955 after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Atomera Incorporated (NASDAQ: ATOM) jumped 19.7 percent to $6.12 after reporting Q1 results.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 16.4 percent to $21.00 after reporting strong preliminary results for the third quarter.
    Titan International, Inc. (NYSE: TWI) shares rose 16.4 percent to $12.21 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares gained 14.9 percent to $63.75 following Q1 results.
    Control4 Corporation (NASDAQ: CTRL) shares climbed 14.5 percent to $23.98 folloiwng strong Q1 results.
    B&G Foods, Inc. (NYSE: BGS) climbed 12.6 percent to $25.40 after reporting Q1 earnings.
    HMS Holdings Corp (NASDAQ: HMSY) shares gained 10 percent to $19.59 after reporting upbeat quarterly earnings.
    Viavi Solutions Inc. (NASDAQ: VIAV) rose 7 percent to $10.09 following Q3 r
  • [By Lisa Levin] Gainers
    Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) shares jumped 29.86 percent to close at $2.87 on Friday.
    Commercial Vehicle Group, Inc. (NASDAQ: CVGI) shares gained 28.87 percent to close at $8.75 after reporting upbeat Q1 earnings.
    Mexco Energy Corporation (NYSE: MXC) gained 27.02 percent to close at $5.4744.
    Carbon Black, Inc. (NASDAQ: CBLK) climbed 26 percent to close at $23.94. Carbon Black priced its IPO at $19 per share.
    Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 25.64 percent to close at $42.44 after the FDA approved the company's Andexxa, the only antidote indicated for patients treated with rivaroxaban and apixaban.
    Natural Grocers by Vitamin Cottage, Inc. (NYSE: NGVC) rose 23.19 percent to close at $8.50 after reporting Q2 results.
    California Resources Corporation (NYSE: CRC) shares gained 22.45 percent to close at $31.58 following upbeat Q1 earnings.
    Atomera Incorporated (NASDAQ: ATOM) gained 22.31 percent to close at $6.25 after reporting Q1 results.
    Medifast, Inc. (NYSE: MED) shares jumped 22.27 percent to close at $121.46 after the company reported strong Q1 results and raised its FY18 guidance.
    Jerash Holdings (US), Inc. (NASDAQ: JRSH) gained 20.86 percent to close at $8.46.
    Pandora Media, Inc. (NYSE: P) rose 19.83 percent to close at $6.89 after reporting strong quarterly results.
    Shake Shack Inc (NYSE: SHAK) rose 18.01 percent to close at $55.95 on Friday after the company reported upbeat results for its first quarter and raised its FY18 guidance.
    Super Micro Computer, Inc. (NASDAQ: SMCI) rose 17.73 percent to close at $21.25 after reporting strong preliminary results for the third quarter.
    Schmitt Industries, Inc. (NASDAQ: SMIT) rose 17.41 percent to close at $2.36.
    Titan International, Inc. (NYSE: TWI) shares gained 16.78 percent to close at $12.25 following Q1 earnings.
    Integer Holdings Corporation (NYSE: ITGR) shares rose 14.23 percent to close at $63.40 following Q1 result
  • [By ]

    Cramer was bearish on BGC Partners (BGCP) , Dr Pepper Snapple (DPS) , Sterling Construction Co. Inc.  (STRL) and B&G Foods (BGS) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Logan Wallace]

    B&G Foods, Inc. (NYSE:BGS) was the target of some unusual options trading on Thursday. Investors acquired 2,993 put options on the stock. This represents an increase of approximately 1,339% compared to the average daily volume of 208 put options.

  • [By ]

    B&G Foods (BGS) : “No, we’re going to stay away. This group is a snake pit.”

    Masco (MAS) : “I like Masco. We have a housing shortage and that’s good for Masco.”

investing forum

The U.K. doesn’t yet know what Brexit means, what economic impact it will have or how to execute it.

These are the big takeaways from a week of turmoil that prevented Prime Minister Theresa May from unlocking the second phase of Brexit talks about the future terms of trade between the U.K. and the European Union.

Negotiations continue, but time is tight: Britain will crash out of the EU if no deal is agreed by March 2019, an outcome that the U.S. Chamber of Commerce warned Wednesday would be “devastating.”

Businesses are preparing to move jobs and investment out of the U.K. in early 2018 if trade talks haven’t started.

Nervous investors have pushed the pound down against the dollar this week.

Here’s why:

1. Britain doesn’t know what Brexit means

The biggest question Britain must answer is what kind of relationship it wants with the EU, its biggest export market, once it has left.

May has made clear that the U.K. will leave the EU’s internal market and customs union. But beyond those red lines, little has been settled.

investing forum: Multi Packaging Solutions International Limited(MPSX)

Advisors’ Opinion:

  • [By Bradley Seth McNew]

    Multi Packaging Solutions International Ltd. (NYSE:MPSX) shares jumped 23% as of noon EST today, on the news that the packaging company would be acquired by WestRock Company (NYSE:WRK) in a deal worth $2.3 billion, including nearly $900 million of debt.

investing forum: Methanex Corporation(MEOH)

Advisors’ Opinion:

  • [By Jim Robertson]

    Back in February of last year, we suggested Methanex Corporation (MEOH), which ended up providing us with some pretty good gains in a fairly short amount of time, and based on what’s happening with the stock technically right now, it could be another gainer over the next several days to few weeks.

investing forum: LCA-Vision Inc.(LCAV)

Advisors’ Opinion:

  • [By Lisa Levin]

    Medical Practitioners: This industry jumped 2.82% by 10:15 am. The top performer in this industry was LCA-Vision (NASDAQ: LCAV), which rose 2.9%. LCA-Vision’s trailing-twelve-month revenue is $91.12 million.

investing forum: FMC Technologies, Inc.(FTI)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Following a series of M&A announcements in the oilfield-services sector since the onset of the oil market downturn, French oil-field service company Technip and U.S. oilfield equipment company FMC Technologies (NYSE:FTI) hooked up in an all-stock deal valuing the combined company at $13 billion. Shareholders of each company will own 50% of the combined entity, to be named TechnipFMC, which implies a roughly $6.5 billion acquisition valuation for each entity. The transaction, which should close early next year, will “combine Technip’s innovative systems and solutions, state-of-the-art assets, engineering strengths, and project management capabilities with FMC Technologies’ leading technology, manufacturing, and service capabilities.” Further, it should save $400 million in annual costs by 2019. Moreover, it will enable the combined company to compete better against larger oil-field service rivals Baker Hughes (NYSE:BHI), Halliburton (NYSE:HAL), and Schlumberger (NYSE:SLB), which have all gained strength during the downturn either through M&A activities or cost savings initiatives.

investing forum: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By David Zeiler]

    Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.

    Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.

  • [By Stephen Mack]

    Galapagos NV (Nasdaq: GLPG) is our big winner so far, gaining 578.8% since Money Morning Executive Editor Bill Patalon shared his recommendation with Money Morning readers in April 2012. The S&P 500 has gained 75.4% in the same time. Bill has renewed his recommendation for the Belgian biotech several times over the years, saying in 2016 that it has “an established history of piling on gains.” With an average gain of 110% a year, it’s hard to argue with that.

30 Stocks Moving In Friday's Mid-Day Session

ShiftPixy Inc (NASDAQ: PIXY) shares climbed 97 percent to $4.27 following Q4 earnings report. ShiftPixy reported sales of $20.244 million in the fourth quarter, up from $8.46 million year-over-year. The company sees first quarter gross billings of $40 million.
Longfin Corp (NASDAQ: LFIN) shares climbed 56.8 percent to $8.45 after the company announced agreement to acquire Ziddu.com.
Diana Containerships Inc (NASDAQ: DCIX) shares rose 22.59 percent to $5.97 after falling 7.06 percent on Thursday.
Riot Blockchain, Inc. (NASDAQ: RIOT) shares climbed 14.51 percent to $28.605 after gaining 8.47 percent on Thursday.
Wins Finance Holdings Inc (NASDAQ: WINS) shares gained 14.2 percent to $136.00.
Educational Development Corporation (NASDAQ: EDUC) shares rose 13.1 percent to $16.00 after the company reported Q3 and year-to-date revenue.
Crocs, Inc. (NASDAQ: CROX) climbed 12.4 percent to $12.30. Stifel Nicolaus upgraded Crocs from Hold to Buy.
TiGenix NV (NASDAQ: TIG) gained 12.4 percent to $24.36. Takeda and TiGenix disclosed that Cx601 has received a positive CHMP opinion for treatment of complex perianal fistulas in Crohn's disease. Mesoblast has granted Tigenix exclusive global patent license to use adipose-derived mesenchymal stem cells in local treatment of fistulae.
Marathon Patent Group Inc (NASDAQ: MARA) jumped 10.8 percent to $6.0206 after falling 4.57 percent on Thursday.
Professional Diversity Network Inc (NASDAQ: IPDN) shares rose 10 percent to $4.10.
Under Armour Inc (NYSE: UAA) shares jumped 9 percent to $15.06. Stifel Nicolaus upgraded Under Armour from Hold to Buy.
FormFactor, Inc. (NASDAQ: FORM) shares gained 8.8 percent to $16.21.
DDR Corp (NYSE: DDR) climbed 8.8 percent to $8.66 after announcing the the creation of a retail value trust, which will be spun off with approximately $3 billion of Gross Book Value of assets and business. The company will complete the portfolio transformation while maintaining scale and balance sheet strength and that the strategy will realize private market asset values.
Galapagos NV (ADR) (NASDAQ: GLPG) shares gained 7.4 percent to $90.71 after the company reported that it has exercised co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries.
Hess Corp. (NYSE: HES) climbed 4.7 percent to $44.42 after a WSJ report says that activist investor Elliott seeks to replace John Hess as CEO or get him to consider a sale. The activist investor also seeks a dividend cut and more buybacks.
U.S. Global Investors, Inc. (NASDAQ: GROW) gained 4.6 percent to $5.915 after climbing 7.82 percent on Thursday.
RumbleON Inc (NASDAQ: RMBL) shares gained 3.1 percent to $5.4594 after announcing a strategic partnership with Sonic Automotive Inc (NYSE: SAH).

Losers
TrovaGene Inc (NASDAQ: TROV) shares dipped 43.1 percent to $0.2449. Trovagene priced its 15 million share common stock offering at $0.30 per share.
One Horizon Group Inc (NASDAQ: OHGI) shares dipped 21.1 percent to $2.4299 after surging 185.16 percent on Thursday.
Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares dropped 15.6 percent to $0.53 after the company agreed to be acquired by Genoptix for $10 million.
Verastem Inc (NASDAQ: VSTM) shares declined 12.1 percent to $3.21 after announcing public offering of common stock.
Frontier Communications Corp (NASDAQ: FTR) dropped 10 percent to $8.6401. Barclays initiated coverage on Frontier Communications with an Underweight rating and a $7.00 price target.
Fitbit Inc (NYSE: FIT) shares dropped 7.7 percent to $6.2950. Stifel Nicolaus downgraded Fitbit from Hold to Sell.
CSX Corporation (NYSE: CSX) dipped 7.7 percent to $52.88 following announcement that the CEO Hunter Harrison had taken medical leave.
Oracle Corporation (NYSE: ORCL) shares declined 5.6 percent to $47.37. Oracle posted upbeat earnings for its second quarter, but revenue from its cloud-based business missed analysts' estimates.
SG Blocks Inc (NASDAQ: SGBX) shares slipped 5.5 percent to $5.20.
Global Blood Therapeutics Inc (NASDAQ: GBT) fell 5.3 percent to $37.30. Global Blood Therapeutics reported a $100 million common stock offering.
bebe stores, inc. (NASDAQ: BEBE) shares fell 5.1 percent to $4.10.
Yield10 Bioscience Inc (NASDAQ: YTEN) shares dropped 5 percent to $3.45 after dropping 17.153 percent on Thursday.
The Chefs' Warehouse, Inc. (NASDAQ: CHEF) slipped 2.7 percent to $19.50 after the company reported commencement of public offering of common stock.

30 Stocks Moving In Friday's Mid-Day Session

ShiftPixy Inc (NASDAQ: PIXY) shares climbed 97 percent to $4.27 following Q4 earnings report. ShiftPixy reported sales of $20.244 million in the fourth quarter, up from $8.46 million year-over-year. The company sees first quarter gross billings of $40 million.
Longfin Corp (NASDAQ: LFIN) shares climbed 56.8 percent to $8.45 after the company announced agreement to acquire Ziddu.com.
Diana Containerships Inc (NASDAQ: DCIX) shares rose 22.59 percent to $5.97 after falling 7.06 percent on Thursday.
Riot Blockchain, Inc. (NASDAQ: RIOT) shares climbed 14.51 percent to $28.605 after gaining 8.47 percent on Thursday.
Wins Finance Holdings Inc (NASDAQ: WINS) shares gained 14.2 percent to $136.00.
Educational Development Corporation (NASDAQ: EDUC) shares rose 13.1 percent to $16.00 after the company reported Q3 and year-to-date revenue.
Crocs, Inc. (NASDAQ: CROX) climbed 12.4 percent to $12.30. Stifel Nicolaus upgraded Crocs from Hold to Buy.
TiGenix NV (NASDAQ: TIG) gained 12.4 percent to $24.36. Takeda and TiGenix disclosed that Cx601 has received a positive CHMP opinion for treatment of complex perianal fistulas in Crohn's disease. Mesoblast has granted Tigenix exclusive global patent license to use adipose-derived mesenchymal stem cells in local treatment of fistulae.
Marathon Patent Group Inc (NASDAQ: MARA) jumped 10.8 percent to $6.0206 after falling 4.57 percent on Thursday.
Professional Diversity Network Inc (NASDAQ: IPDN) shares rose 10 percent to $4.10.
Under Armour Inc (NYSE: UAA) shares jumped 9 percent to $15.06. Stifel Nicolaus upgraded Under Armour from Hold to Buy.
FormFactor, Inc. (NASDAQ: FORM) shares gained 8.8 percent to $16.21.
DDR Corp (NYSE: DDR) climbed 8.8 percent to $8.66 after announcing the the creation of a retail value trust, which will be spun off with approximately $3 billion of Gross Book Value of assets and business. The company will complete the portfolio transformation while maintaining scale and balance sheet strength and that the strategy will realize private market asset values.
Galapagos NV (ADR) (NASDAQ: GLPG) shares gained 7.4 percent to $90.71 after the company reported that it has exercised co-promotion option for filgotinib with collaboration partner Gilead Sciences in eight European countries.
Hess Corp. (NYSE: HES) climbed 4.7 percent to $44.42 after a WSJ report says that activist investor Elliott seeks to replace John Hess as CEO or get him to consider a sale. The activist investor also seeks a dividend cut and more buybacks.
U.S. Global Investors, Inc. (NASDAQ: GROW) gained 4.6 percent to $5.915 after climbing 7.82 percent on Thursday.
RumbleON Inc (NASDAQ: RMBL) shares gained 3.1 percent to $5.4594 after announcing a strategic partnership with Sonic Automotive Inc (NYSE: SAH).

Losers
TrovaGene Inc (NASDAQ: TROV) shares dipped 43.1 percent to $0.2449. Trovagene priced its 15 million share common stock offering at $0.30 per share.
One Horizon Group Inc (NASDAQ: OHGI) shares dipped 21.1 percent to $2.4299 after surging 185.16 percent on Thursday.
Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares dropped 15.6 percent to $0.53 after the company agreed to be acquired by Genoptix for $10 million.
Verastem Inc (NASDAQ: VSTM) shares declined 12.1 percent to $3.21 after announcing public offering of common stock.
Frontier Communications Corp (NASDAQ: FTR) dropped 10 percent to $8.6401. Barclays initiated coverage on Frontier Communications with an Underweight rating and a $7.00 price target.
Fitbit Inc (NYSE: FIT) shares dropped 7.7 percent to $6.2950. Stifel Nicolaus downgraded Fitbit from Hold to Sell.
CSX Corporation (NYSE: CSX) dipped 7.7 percent to $52.88 following announcement that the CEO Hunter Harrison had taken medical leave.
Oracle Corporation (NYSE: ORCL) shares declined 5.6 percent to $47.37. Oracle posted upbeat earnings for its second quarter, but revenue from its cloud-based business missed analysts' estimates.
SG Blocks Inc (NASDAQ: SGBX) shares slipped 5.5 percent to $5.20.
Global Blood Therapeutics Inc (NASDAQ: GBT) fell 5.3 percent to $37.30. Global Blood Therapeutics reported a $100 million common stock offering.
bebe stores, inc. (NASDAQ: BEBE) shares fell 5.1 percent to $4.10.
Yield10 Bioscience Inc (NASDAQ: YTEN) shares dropped 5 percent to $3.45 after dropping 17.153 percent on Thursday.
The Chefs' Warehouse, Inc. (NASDAQ: CHEF) slipped 2.7 percent to $19.50 after the company reported commencement of public offering of common stock.

top stocks today to buy

Chinese regulators on Monday declared initial coin offerings illegal, dealing a blow to the latest financial-markets mania and sending the prices of the two leading cryptocurrencies, bitcoin and ether, tumbling.

The move by China, which included a call for fundraising activities through the digital tokens to cease immediately, follows on the heels of a recent warning by the U.S. Securities and Exchange Commission that it may treat the coins as securities. That potentially opens these unregulated offerings to greater oversight.

top stocks today to buy: Neogen Corporation(NEOG)

Advisors’ Opinion:

  • [By Lisa Levin] Related LOV Match Group And Spark Networks: A Valentine's Day Case Study 20 Biggest Mid-Day Losers For Thursday
    Related VKTX 15 Biggest Mid-Day Losers For Tuesday 18 Biggest Mid-Day Losers For Wednesday Companies Reporting Before The Bell
    Canadian Solar Inc. (NASDAQ: CSIQ) is expected to report its quarterly earnings at $0.32 per share on revenue of $690.27 million.
    General Mills, Inc. (NYSE: GIS) is projected to report its quarterly earnings at $0.71 per share on revenue of $3.84 billion.
    Coca-Cola European Partners Plc (NYSE: CCE) is estimated to report its quarterly earnings at $0.45 per share on revenue of $2.72 billion.
    Lands' End, Inc. (NASDAQ: LE) is expected to report its quarterly earnings at $0.35 per share on revenue of $459.43 million.
    Francesca's Holdings Corp (NASDAQ: FRAN) is estimated to report its quarterly earnings at $0.37 per share on revenue of $145.91 million.
    Cheetah Mobile Inc (ADR) (NYSE: CMCM) is projected to report its quarterly earnings at $0.06 per share on revenue of $178.04 million.
    Neogen Corporation (NASDAQ: NEOG) is estimated to report its quarterly earnings at $0.27 per share on revenue of $90.05 million.
    Lennar Corporation (NYSE: LEN) is projected to post earnings for its first quarter.
    Fifth Street Asset Management Inc (NASDAQ: FSAM) is expected to report its quarterly earnings at $0.14 per share on revenue of $25.12 million.

     

top stocks today to buy: TripAdvisor, Inc.(TRIP)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows Angie’s List basically back to breakeven while other online review stocks like small cap Yelp Inc (NYSE: YELP) and mid cap Tripadvisor Inc (NASDAQ: TRIP) have performed a bit better with mid capacquirer IAC has been a better performer:

  • [By Peter Graham]

    Online travel stock Tripadvisor Inc (NASDAQ: TRIP) reportedQ1 2017 earnings after the market closed on Tuesday with shares up in afterhours /premarket trading. Q1 revenue rose 6% (or 7% on a constant currency basis) to $372 million as hotel revenue grew 4% to $314 million and non-hotel revenue rose 18% to $58 million.Net income was $13 million versus $29 million. Key business metrics cited in the earnings report included:

  • [By Casey Wilson]

    This next company comes as a surprise, as it is one that has served over 300 million people around the world…

    Failing Company No. 3: TripAdvisor Inc. (Nasdaq: TRIP)

    The website that changed the way user-generated content is used for travel is feeling the pressure from competition.

top stocks today to buy: Zogenix, Inc.(ZGNX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Zogenix, Inc. (NASDAQ: ZGNX) was down, falling around 8 percent to $35.82 after the company disclosed new efficacy and safety data from its pivotal Phase 3 clinical trial of ZX008 in Dravet syndrome.

  • [By Lisa Levin]

    Zogenix, Inc. (NASDAQ: ZGNX) was down, falling around 11 percent to $34.75 after the company disclosed new efficacy and safety data from its pivotal Phase 3 clinical trial of ZX008 in Dravet syndrome.

top stocks today to buy: Galapagos NV(GLPG)

Advisors’ Opinion:

  • [By David Zeiler]

    Bill Patalon’s initial stock pick was Galapagos NV (Nasdaq ADR: GLPG), a Belgian biotech company.

    Patalon was attracted to Galapagos’ strategy to target “orphan diseases,” afflictions that strike rarely and so often go ignored by the Big Pharma companies. He also liked that Galapagos had more than 50 drug discovery programs underway, and that it already had licensing agreements with several bigger players in the industry.

  • [By Stephen Mack]

    Galapagos NV (Nasdaq: GLPG) is our big winner so far, gaining 578.8% since Money Morning Executive Editor Bill Patalon shared his recommendation with Money Morning readers in April 2012. The S&P 500 has gained 75.4% in the same time. Bill has renewed his recommendation for the Belgian biotech several times over the years, saying in 2016 that it has “an established history of piling on gains.” With an average gain of 110% a year, it’s hard to argue with that.